Is Orchestra Biomed (OBIO) stock Halal?

Orchestra Biomed is a pioneering biomedical company dedicated to the development and commercialization of high-impact medical therapies. This asset focuses on addressing significant unmet medical needs across multiple therapeutic areas, with an emphasis on cardiovascular diseases. Through its innovative bioelectronics and acquirer/delivery platform, the company is at the forefront of integrating advanced technology with clinical applications to enhance patient outcomes. Before any of that matters to a Muslim investor, one question comes first: is Orchestra Biomed stock Halal?

Is Orchestra Biomed Shariah compliant?

No. In the October 2026 screening Orchestra Biomed (OBIO) does not pass AAOIFI screening: it fails the interest-bearing investments screen. The Shariah case on a technology company like Orchestra Biomed is rarely about the product. What AAOIFI Shariah Standard No. 21 examines is the money around the product: cash parked in instruments that earn Riba, borrowing measured against a market capitalisation that moves daily, and any incidental income from sources Islam prohibits, which must stay below 5% of revenue.

Does Orchestra Biomed pass the business activity test?

The activity screen is only part of the picture this month: Orchestra Biomed currently fails the interest-bearing investments screen, so the overall verdict is not compliant regardless of the business itself. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.

Is Orchestra Biomed's income Halal?

Yes, within AAOIFI's tolerance. Orchestra Biomed's income from non-permissible sources stays below 5% of revenue in the October 2026 screening.

Does Orchestra Biomed meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing investments currently exceed the 30% cap, measured against a market capitalisation of $374M (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for Orchestra Biomed?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read Why a Halal Stock Screener Matters for Halal Investing